Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Curcumin may improve cancer radiotherapy by making cancer cells more sensitive to radiation and protecting normal cells.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Total skin electron therapy is an effective treatment for mycosis fungoides, balancing effectiveness and side effects.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Plucked hair can effectively monitor drug effects in cancer treatment.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

The treatment was effective and tolerable for advanced gastric cancer.

Alitretinoin may help treat alopecia areata.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

New molecules can prevent cell death in hair follicles.

Ritlecitinib is safe and may effectively treat alopecia areata.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Penguin Cold Caps help most patients keep at least half their hair during chemotherapy.

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Exosomes show promise for targeted treatment of HER2-positive breast cancer.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

HDR electronic brachytherapy effectively treats nonmelanoma skin cancer with good cosmetic results and minimal side effects.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Compound 7p shows strong potential as an anticancer agent.